Abstract: |
Vulvar and vaginal cancers are the least common gynecological malignancies and comprise a number of different histological subtypes including squamous cell carcinoma, melanoma, basal cell carcinoma, sarcoma, and others. Risk factors for these cancers are dependent on histological type and can include human papillomavirus exposure, lichen sclerosis, race, and age. Radical surgery has traditionally been the mainstay of therapy. However, more conservative surgical excision and limited lymph node sampling have become more widely accepted as they have been shown to have excellent oncological outcomes while sparing surgical morbidity. Similarly, advances in systemic therapy, specifically with respect to immunotherapy for vulvar melanoma, have changed the treatment paradigm for many of these cancers. Successful treatment of vulvar and vaginal cancers requires a patient centered, multidisciplinary approach. © 2017 John Wiley & Sons Ltd. |